Zhong M - Search Results

1

Transcriptional profiling of long-intergenic noncoding RNAs in lung squamous cell carcinoma and its value in diagnosis and prognosis.

Liu J, Yao Y, Hu Z, Zhou H, Zhong M. Liu J, et al. Among authors: zhong m. Mol Genet Genomic Med. 2019 Dec;7(12):e994. doi: 10.1002/mgg3.994. Epub 2019 Oct 16. Mol Genet Genomic Med. 2019. PMID: 31617686 Free PMC article.

2

Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.

Zhu H, Pei HP, Zeng S, Chen J, Shen LF, Zhong MZ, Yao RJ, Shen H. Zhu H, et al. J Proteome Res. 2009 Aug;8(8):3969-76. doi: 10.1021/pr900287a. J Proteome Res. 2009. PMID: 19507834

3

Facile synthesis of monodispersed Fe2O3 nanoparticles and its cellular uptake and cytotoxicity studies.

Zhou H, Xiao L, Luo Y, Chen JH, Xu JH, Zeng Y, Zhong MZ. Zhou H, et al. J Nanosci Nanotechnol. 2013 Oct;13(10):6560-5. doi: 10.1166/jnn.2013.7748. J Nanosci Nanotechnol. 2013. PMID: 24245115

4

High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.

Zhou H, Chen JH, Hu J, Luo YZ, Li F, Xiao L, Zhong MZ. Zhou H, et al. J Cancer Res Clin Oncol. 2014 Apr;140(4):633-43. doi: 10.1007/s00432-014-1616-4. Epub 2014 Feb 19. J Cancer Res Clin Oncol. 2014. PMID: 24549739

5

Overexpression of ANLN contributed to poor prognosis of anthracycline-based chemotherapy in breast cancer patients.

Wang Z, Chen J, Zhong MZ, Huang J, Hu YP, Feng DY, Zhou ZJ, Luo X, Liu ZQ, Jiang WZ, Zhou WB. Wang Z, et al. Cancer Chemother Pharmacol. 2017 Mar;79(3):535-543. doi: 10.1007/s00280-017-3248-2. Epub 2017 Feb 27. Cancer Chemother Pharmacol. 2017. PMID: 28243684

6

STAT3 mediates multidrug resistance of Burkitt lymphoma cells by promoting antioxidant feedback.

Zeng R, Tang Y, Zhou H, Liu Y, Huang J, Li L, Liu W, Feng Y, Zhou Y, Chen T, Zhang L, Zhong M. Zeng R, et al. Among authors: zhong m. Biochem Biophys Res Commun. 2017 Jun 17;488(1):182-188. doi: 10.1016/j.bbrc.2017.05.031. Epub 2017 May 5. Biochem Biophys Res Commun. 2017. PMID: 28483518

7

Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study.

Li JW, Li YJ, Zhong MZ, Liu XL, Li J, Li KL, Liu XY, Zhou F, OuYang Z, Sun ZY, Huang LJ, He JQ, Zhou H, Yi PY. Li JW, et al. Eur J Haematol. 2018 Mar;100(3):247-256. doi: 10.1111/ejh.13004. Epub 2018 Jan 11. Eur J Haematol. 2018. PMID: 29194798

8

Problems to affect long-term survival for breast cancer patients: An observational study of subsequent lung/bronchus malignancies.

Liu J, Hu Z, Feng Y, Zeng S, Zhong M. Liu J, et al. Among authors: zhong m. Medicine (Baltimore). 2018 Sep;97(39):e12603. doi: 10.1097/MD.0000000000012603. Medicine (Baltimore). 2018. PMID: 30278574 Free PMC article.

9

Prognostic Factors and Treatment Strategies for Intrahepatic Cholangiocarcinoma from 2004 to 2013: Population-Based SEER Analysis.

Liu J, Zhong M, Feng Y, Zeng S, Wang Y, Xu H, Zhou H. Liu J, et al. Among authors: zhong m. Transl Oncol. 2019 Nov;12(11):1496-1503. doi: 10.1016/j.tranon.2019.05.020. Epub 2019 Aug 22. Transl Oncol. 2019. PMID: 31446308 Free PMC article.

10

linc01088 promotes cell proliferation by scaffolding EZH2 and repressing p21 in human non-small cell lung cancer.

Liu JQ, Feng YH, Zeng S, Zhong MZ. Liu JQ, et al. Life Sci. 2020 Jan 15;241:117134. doi: 10.1016/j.lfs.2019.117134. Epub 2019 Dec 4. Life Sci. 2020. Retraction in: Life Sci. 2023 Nov 15;333:122175. doi: 10.1016/j.lfs.2023.122175 PMID: 31811854 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,860 results

Search Page

Filters